The example of Jiangsu in the science and technology board: 88 "hard technology" companies cast a trillion yuan market value carrier

At 9:30 am on July 22, 2019, with a gong rang from the Shanghai Stock Exchange's trading hall, the science and technology board officially opened. The sound of this gong marks the full implementation of the major reform of China's capital market registration system.

Focus on "hard technology" and deeply cultivate the "test field". This is positioned in the unique sector of technological innovation enterprises with high core technology and high market recognition, and has officially opened a new chapter in China's capital market with determination to firmly control the development of science and technology development in its own hands.

In the past three years, Jiangsu enterprises have shown hard core power in the development and growth of science and technology boards: 88 "Jiangsu" listed companies have won the "most" of the number of nationwide and achieved the top ten in many ranking. Listed companies in the region have achieved a total of 104.2 billion yuan in first fundraising. Focusing on Nanjing, Nanjing's territory of the biomedical "science and technology innovation team" performed well, and came out of a number of outstanding enterprises such as Nuo Weizan, South Micro -Medicine, and Yaokang Biological.

For newcomers to win, those who think about change, the science and technology board of the age of three years of age has been from scratch, and they are preferred.

"Hard Technology" enterprise shining capital stage

Three years ago, on the day of the opening of the Science and Technology Board, Huaxingyuan, located at No. 8 Qingqiu Lane, Suzhou Industrial Park, was lucky to become the first listed company in the country's top "688". "688001".

Since then, Jiangsu enterprises have won multiple "firsts" of the science and innovation board: the first landing of the science and technology board, and the Huaxing Yuanchuang, which disclosed the reorganization plan in the year of listing; Advantages) Listing, Zezheng Pharmaceutical, which is not profitable in the A -share market, is the first to be listed in the market; the first "green -chip listing" China Resources Micro is introduced in the first section to introduce the "green shoe mechanism" (over -distribution right selection) The tolerance of the board for listed companies was fully displayed in Jiangsu.

Many Jiangsu companies go to the science and technology board, and they are hoping to use the complete recreational and mergers and acquisitions and reorganization service systems of the capital market to better realize scientific and technological innovation.

According to the statistics of the Volkswagen Securities Journal, Wind data shows that as of now, the total number of first -issuing funds in the 88 Jiangsu region has achieved a total of about 104.2 billion yuan, accounting for 15.75%of the total fundraising of science and innovation board.

In late April 2022, Na core micro -landing science and technology board, the company finally issued 5.811 billion yuan, becoming the highest fundraising company in Jiangsu region. According to the NAND micro -listing manual, these raised funds will be mainly used for signal chain chip development and system applications, and research and development centers.

Through the reorganization and issuance convertible bonds, Huaxingyuan, the first share of the "Science and Technology Board", has initially formed a good pattern of the company's development of the three main business sectors of tablets, semiconductor, and intelligent wearable wearables, and its new energy vehicle testing The business has also been successfully recognized by many new energy vehicles in China.

As the first company in the history of the A -share capital market to be profitable, Zezhe Pharmaceutical achieved revenue of 190 million yuan in 2021, an increase of 588.19%year -on -year. Innovation Pharmaceutical Company has a large investment in drug research and development in the early stage and long cycles. In the initial stage, there is a general loss of losses and urgently need financial support. The science and technology board will undoubtedly bring the capital "timely rain" to Zezhe Pharmaceutical.

Different from the motherboard, the 20%rising decline system is an innovation and breakthrough in the Rules of the A -share market trading rules, and it is also an important trading feature of the science and technology board. "Public Securities News" found that the upper sound electronics with the largest number of daily limit since the listing of science and technology board listed companies in the Jiangsu region has recorded 7 daily limit for more than a year.

"The 20%rising decline actually allows the market to decide to fluctuate." Huatai Berry Fund's point of view believes that "the rise and fall from 10%to 20%, it is not easy to make a board, and the liquidity increases accordingly."

In addition to the advantages of financing functions and liquidity, the company in the Kyoto Board also has certain brand power.

Jiang Chaochang Jiang Chaoshang once said that after listing, it is obvious that young people, especially fresh graduates, have paid much more attention and recognition of the company. "Our types of chip design are very important to cultivate talent echelons." The attraction and cohesion of talents has consolidated the foundation of the company's continuous improvement of technological innovation and market competitiveness.

Today, the science and technology board is becoming an important way for Jiangsu's "hard technology" enterprises to seek a broader stage.

The gathering effect after "Hundred Family Contention"

The rapid development of the science and technology board also brings a significant industrial agglomeration effect.

The science and technology board can attract the company's "blood nourishing" function behind the coming of enterprises. After Lianrui New Materials, which deeply cultivated industrial powder materials, landed in the science and technology board in May 2022, two industry experts were successfully introduced, thereby breaking through the bottleneck of development.

Specifically, the three major industries of new generation of information technology, biomedicine, and high -end equipment are gathered in the Jiangsu region. According to the statistics of the Volkswagen Securities Journal, there are 32, 20, and 15 science and technology board listed companies involving these three fields, accounting for 76%of the total number of listed companies in the region.

Among the 10 listed companies in Nanjing, 6 are involved in biomedical fields, including domestic molecular reagents leading Nuo Weizan and endoscopic diagnosis and therapy leading south Micro -Medicine. Yaocang Bio, which was listed in April this year, became the first new R & D institution in Nanjing to realize the listing of biomedicine.

"Hundreds of Rangers" in Nanjing's science and technology board biomedical listed company is a reflection of the vigorous development of the local biomedical industry. It is estimated that by 2025, the scale of Nanjing's new medicine and life and health industries may exceed 540 billion yuan. Including Wuxi's semiconductor, Changzhou's photovoltaic, etc., similar industrial agglomeration effects are staged in many cities in Jiangsu: in 2021, Wuxi integrated circuit industry scale exceeds 175 billion yuan, ranking second in the country, of which packaging testing and supporting nationwide scale First; relying on the leading position and brand effect in the industry, Changzhou has attracted a large number of photovoltaic companies such as Yijing Optoelectronics to land.

While forming a "industrial cluster", the capital market has also frequently thrown olive branches. In June this year, Nuo Weizan, located in the Nanjing Economic and Technological Development Zone Science and Technology Development Zone, once attracted more than 100 institutions to investigate. Subsequently, many securities firms such as Guolian Securities, Guosheng Securities, and Zhongtai Securities gave the company a "buy" rating.

Example of Jiangsu: Take the first, compete for upstream

Huaxingyuan's main business is the development, production and sales of flat -screen display and integrated circuit detection equipment. For the company's chairman Chen Wenyuan, the number "001" is a honor and pressure, but it is more expectations for the future: "We want to be an invisible champion in the field." In his opinion, listing is just the beginning.

Huaxingyuan has become a microcosm of the "hard technology" enterprises in the Jiangsu region.

In the past three years, Jiangsu has handed over a high score answer sheet on the science and technology board. Since May 18, 2020, after Gobber landed on the Science and Technology Board, the number of listed companies in the Jiangsu regional science and technology board began to lead the country. With August 11 this year, the number of listed companies in the Jiangsu regional science and technology board listed in the Jiangsu region has increased steadily to 88, accounting for nearly 1/5 of the 448 science and innovation board listed companies.

While winning the number of laurels, the quality of listed companies in the Jiangsu regional science and technology board is also "hard", and it has won a good ranking in the top ten rankings.

As of press time, the total market value of the national science and technology board listed company was on the top ten, and Tianhe Light Energy and China Resources Micro from Jiangsu were on the list. Among them, Tianheguang can rank second at the list with a market value of 180 billion yuan. The total market value of listed companies in the Jiangsu regional science and technology board has also been nearly 1.2 trillion yuan.

Judging from the performance of the stock price since listing, there are 7 listed companies in the top ten of the science and technology board. The Outviers, Dongwei Technology, and Gudewei have firmly occupied the top three of the science and technology board with a cumulative increase of more than 13 times. s position. Outvi, which involving photovoltaic, machine vision, and intelligent manufacturing, has not stopped the pace of stock price increase since its listing, and won the first place with a cumulative increase of nearly 15 times.

Among the top ten high -priced stocks of the science and technology board, Siruipu, Na core, and Gudewei from Jiangsu have successfully won the three seats. As of August 11, the 100 yuan shares of the science and technology board listed in the Jiangsu region reached 15 yuan.

While gaining the favor of investors, the performance of listed companies in the Jiangsu regional science and technology board has also been affirmed by the market. In 2021, listed companies in the region recorded a total of 137.319 billion yuan, a year -on -year increase of 39.49%; net profit was 16.282 billion yuan, an increase of 39.32%year -on -year. Tianheguang can once again "dominate the list". While winning the first revenue in the region, it ranks second in the country in the country's revenue list.

As an important indicator of the inspection science and technology innovation, in 2021, the total amount of R & D investment in the listed company in the Jiangsu area of ​​the science and technology board reached 10.729 billion yuan, an increase of 47.8%year -on -year. Of the 88 listed companies in the Jiangsu area, 48 of R & D expenditure accounted for more than 8%of operating income. Among them, the four unprofitable Rainie, Dazhe Pharmaceuticals, cutting -edge biology, and Zezhe Pharmaceutical R & D expenditure all exceeded their revenue, which also reflects the characteristics of encouraging listed companies to develop and innovate.

Nanjing Power: "God Beast Solution" after the science and technology innovation board

Jiangsu's high inclusiveness of scientific research innovation, capital, and its excellent business environment and science and technology industry policies have supported a large number of backup forces with "hard power".

The "High -quality Development Action Plan for Listed Companies in Jiangsu Province (2021-2025)" released in 2021 proposes that by the end of 2025, it is necessary Provide strong policy support for scientific and technological innovation enterprises.

In March 2022, the Jiangsu Provincial Department of Science and Technology launched a special action to promote the development of "spring breeze" to promote the development of SMEs, and proposed to strive to increase the number of scientific and technological small and medium -sized enterprises in the province by 2025 to achieve the "four subjects" standard (with key core technology The scientific and technological products and scientific and technological personnel account for more than 60%of the scientific and technological achievements represented by high -value intellectual property rights, and the intensity of R & D investment is higher than 6%). Technology -oriented SMEs add 5,000 new SMEs.

In the cultivation of the science and technology board reserve enterprises, Nanjing gave another "god beast" solution. A total of 535 companies were on the list of Nanjing 2022, which were released in Nanjing in early August this year, the list of unicorn and glaze companies, and these companies were distributed in 24 industries. Among them, the number of high -end equipment is the largest, with a total of 131, accounting for 24.5%of the total; the biomedicine follows closely, a total of 79, accounting for 14.8%of the total. This is quite similar to the distribution of listed companies in the Jiangsu area.

In the five years since the list released in April 2018, Nanjing's unicorns and glaze companies have become the "secret weapon" of "hard technology" for brightening science and innovation boards. Ru Naizan is step by step from cultivating unicorn to unicorn to Jinwei Creative Board. At present, including Nuo Weizan, there are six cutting -edge creatures, Weisi Medical, South Micro -Medicine, Asiaxin Safety, Yaokang Biology, Wandez, etc., and have successfully "graduated" from the list and landed on the list. Science and technology board. This number accounts for 70 % of the total number of listed companies in the Nanjing area. According to the statistics of the Volkswagen Securities News, as of the end of 2021, the total number of companies in the list has been selected in the list over the years, including 15 of the main boards, accounting for 37.5%of the total number of newly listed companies in the city in the same period. These reserve troops are becoming the backbone of Nanjing's "hard technology" listing.

In addition to using the "God Beast" to solve the problem, Nanjing also spent a lot of thoughts on industrial agglomeration. In recent years, Nanjing has promulgated policies such as "Nanjing Casting New Medicine and Life and Health Industry Land Action Plan" and "Nanjing Biomedical Innovation Products (Trial)" and other policies to promote the development of the biomedical industry in the region.

With industrial agglomeration and policy and funding support, Jiangbei New Area "Castle of Gene", Jiangbei New Area "Biomaggon Gathering Area", Jiangning "Yaogu", Nanjing Economic Development Zone "New Medicine Development Base" and other "new drug development bases" Star Yao Jinling began. Today, 14 biomedical companies have successfully landed on the A -share market, and 6 of them constitute the "Nanjing Power" of science and technology board biomedicine.

As of the press release of the "Public Securities News", according to Wind data, the total market value of these six listed companies reached 75.3 billion yuan, accounting for 6.43%of the total market value of the total market value of biomedicine -related biomedicine -related biomedicine.

"688" is the stock code of the science and technology board. "6" means Shun Shun, "8", compared to the "600" of the main board of Shanghai Stock Exchange, the "002" of the Shenzhen motherboard, and the "300" of the GEM. In the future, the infinitely beautiful expectations of Chinese scientific and technological innovation.

Reporter Xu Haifeng Li Qiujie Intern Reporter Chen Yan

- END -